Company Overview
- Headquarters
- 245 First Street Suite 1400, Cambridge MA
- Website
- akebia.com
- mn****@akebia.com
- Phone
- (617) 871-****
- Employees
- 321
- Founded in
- 2007
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:AKB
- NAICS Code
- 54171, 541714, 32, 541, 54, 3254, 325, 5417
- SIC Code
- 87, 28, 873, 283
Financials & Stats
Revenue
$223B
Total Funding Amount
$100M
Who is Akebia Therapeutics Inc
Akebia Therapeutics Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company employs 321 people and generated $223 million in revenue. Akebia Therapeutics focuses on developing and commercializing treatments for individuals living with kidney disease. Akebia Therapeutics is committed to improving the lives of people affected by kidney disease through the advancement of innovative therapies. For more information about Akebia Therapeutics and its work, please visit akebia.com/.
Company Leadership
Akebia Therapeutics Inc Industry Tags
Akebia Therapeutics Inc Tech Stack
Companies Similar to Akebia Therapeutics Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Akebia Therapeutics Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 223M | 1,032 | Emeryville, CA | 2003 | |
| 209M | 164 | Cranbury, NJ | 2007 | |
| 178M | 1,374 | Menlo Park, CA | 2016 | |
| 167M | 667 | Philadelphia, PA | 1996 | |
| 140M | 330 | La Vista, NE | 1971 |